11.06.2014 • News • Bayer • Bristol-Myers Squibb (BMS) • Dede Willams

Dieter Weinand Named to Head Bayer HealthCare Pharmaceuticals

Effective August 1, 2014, Dieter Weinand will become president of Bayer HealthCare Pharmaceuticals and at the same time join the Executive Committee of Bayer HealthCare. He replaces Andreas Fibig, who will leave Bayer on September 1, 2014, to become CEO of International Flavours and Fragrances.

The 53-year-old native of Boppard, Germany is currently president global commercialization & Portfolio management at Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey, USA. He has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry, including stints at Pfizer and Bristol-Myers Squibb.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.